Department of Medicine
University of Pittsburgh
Select a Division
Cardiology
Center for Clinical Pharmacology
Endocrinology and Metabolism
Gastroenterology, Hepatology and Nutrition
General Internal Medicine
Geriatric Medicine
Hematology/Oncology
Infectious Diseases
Pulmonary, Allergy and Critical Care Medicine
Renal-Electrolyte
Rheumatology and Clinical Immunology
Academic Resources
Home
Faculty
Clinical Practice
Educational & Training Programs
Research
Professional Education
Gifts and Support
Contact Us
Other Resources
Arthritis Institute
Lupus Center
Department of Medicine
Divisions of the Department
Internal Medicine Residency Training
Video -"Pittsburgh. A New Vision. A New Tomorrow."
Division of Rheumatology and Clinical Immunology
S700 Biomedical Science Tower
3500 Terrace Street
Pittsburgh, PA 15261
Phone: (412) 383-8000
Chester V. Oddis, MD
Professor of Medicine
Director, Rheumatology fellowship Training Program
Medical Director
Office:
Arthritis Institute
S700 BST, 3500 Terrace Street
Pittsburgh, PA 15261
Phone:
412-383-8861
Fax:
412-648-8864
E-mail:
cvo5@pitt.edu
Education
B.S., University of Pittsburgh, 1976
M.D., Pennsylvania State University College of Medicine, 1980
Training
Internship, Pennsylvania State University College of Medicine, 1884
Residency, University Hosiptal, Pennsylvania State University, 1984
Fellowship, University of Pittsburgh School of Medicine, 1987
Area of Specialization/Research Interest
Myopathies- specifically polymyositis and dermatomyositis
Profile
Dr. Oddis' primary research interest includes the clinical, epidemiologic and serologic aspects of idiopathic inflammatory myopathy. He has written extensively on the diagnosis and management of patients with myositis including use of novel immunosuppressive agents such as tacrolimus. Dr. Oddis is the principal investigator on a recently awarded 5-year NIAMS contract (10/04-10/09) to study the efficacy of a novel biologic agent, rituximab, in adult and pediatric myositis. He has been a co-investigator on two NIH-funded osteoarthritis trials; one (DOXY study) tested the efficacy of doxycycline in preventing the progression of knee osteoarthritis in middle-aged women and the second (GAIT) is assessing the effect of glucosamine and chondroitin sulfate on the pain of osteoarthritis and its radiographic progression. He serves as the Director of the Fellowship Training Program and the Medical Director for outpatient services.
Recent Grants
Title:
Rituximab Therapy in Refractory Adult and Juvenile IIM
Role:
Principal Investigator
Amount:
7,732,309
Funding Agency:
NIH
Start Year:
2004
End Year:
2009
Title:
Knee Stability Training in Individuals with Knee OA
Role:
Co-Investigator
Amount:
53,165
Funding Agency:
NIH
Start Year:
2004
End Year:
2008
For Pub Med search results,
click here
.